Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses

Vaccine

Volumn 18, Issue 27, 2000, Pages 3174-3184

  Apostolopoulos, Vasso ^a   Barnes, Nadine ^a   Pietersz, Geoffrey A ^a   McKenzie, Ian F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Immunotherapy; Macrophage; Mannose receptor; MUC1; Tumor immunity

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MANNOSE RECEPTOR; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; IMMUNIZATION; IMMUNOTHERAPY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 0034662394     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00090-6     Document Type: Article

References (38)

1. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol. 11:1993;191-212.
2. Galew-Lauri J., Farzin F., Gaken J. Novel costimulators in the immune gene therapy of cancer. Cancer Gene Ther. 3:1996;202-213.
3. Van der Bruggen P., Traversari P., Chomez C., Lurquin C., DePlaen E., Van der Eynde B., Knuth A., Boon T. A gene encoding an antigen recognised by cytolytic T. A gene encoding an antigen recognized by CTL on human melanoma. Science. 254:1991;1643-1646.
4. Kawakami Y., Eliyaha S., Delgado C.H., Robbins P.F., Rivoltini L., Topalian S.L., Miki T., Rosenberg S.A. Cloning of the gene coding for a shared human-melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:1994;3515-3519.
5. Disis M.L., Smith J.W., Murphy A.E., Chen W., Cheever M.A. In vitro generation of human CTL specific for peptides derived from the Her-2/neu protooncogene protein. Cancer Res. 54:1994;1071-1076.
6. Theobald M.J., Biggs D., Dittmer A., Levine J., Sherman L.A. Targeting p53 as a general tumor antigen. Proc. Natl. Acad. Sci. USA. 92:1995;11993-11997.
7. Apostolopoulos V., McKenzie I.F.C., Pietersz G.A. Breast cancer immunotherapy - current status and future prospects. Immunol. Cell Biol. 74:1996;457-464.
8. Apostolopoulos V., Pietersz G.A., Loveland B.E., Sandrin M.S., McKenzie I.F.C. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc. Natl. Acad. Sci. USA. 92:1995;10128-10132.
9. Apostolopoulos V., Pietersz G.A., McKenzie I.F.C. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine. 14:1996;930-938.
10. Lofthouse S.A., Apostolopoulos V., Pietersz G.A., McKenzie I.F.C. Induction of T1 (CTL) and/or T2 (antibody) response to a mucin-1 tumor antigen. Vaccine. 15:1997;1586-1593.
11. Apostolopoulos V., Loveland B.E., Pietersz G.A., McKenzie I.F.C. CTL in mice immunized with human Mucin 1 are MHC-restricted. J. Immunol. 155:1995;5089-5094.
12. Karanikas V., Hwang L., Pearson J., Ong C.S., Apostolopobilos V., Vaughan H., Xing P.X., Jamieson G., Pietersz G.A., Tait B., Broadbent R., Thyme G., McKenzie I.F.C. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J. Clinical Invest. 100:1997;2783-2792.
13. Hu X., Charkraborty N.G., Sporn J.R., Kurtzman S.H., Ergin M.T., Mukherji B. Enhancement of cytotoxic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine. Cancer Res. 56:1996;2479-2485.
14. Celluzzi C.M., Mayordomo J.I., Storkus W.J., Lotze M.T., Falo L.D.Jr. Peptide pulsed dendritic cells iduce atigen-pecifi CTL-mdiated protective tumor immunity. J. Exp. Med. 183:1996;283-287.
15. Hermans I.F., Daish A., Rawson M.P., Ronchese F. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge. Cancer Immunol. Immunother. 44:1997;341-347.
16. Flamand V., Sornasse T., Thielemans K., Demanet C., Bakkkus M., Bazin H., Tielemans F., Leo O., Urbain J., Moser M. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:1994;605-610.
17. Andreesen R., Scheibenbogen C., Brugger W., Krause S., Meerpohl H.G., Lesser H.G., Engler H., Lohr G.W. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res. 50:1990;7450-7456.
18. Apostolopoulos V., Xing P.X., Trapani J.A., McKenzie I.F.C. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br. J. Cancer. 67:1993;713-720.
19. Pietersz G.A., Wenjun L., Popovski V., Caruana J-A., Apostolopoulos V., McKenzie I.F.C. Parameters in using mannan-fusion protein (M-FP) to induce cellular immunity. Cancer Immunol. Immunother. 45:1998;321-326.
20. Austyn J.M., Gordon S. F4/80: a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:1981;805-812.
21. Nussenzweig M.C., Steinman R.M., Unkeless J.C., Witmer M.D., Gutchinov B., Cohn Z.A. Studies of the cell surface of mouse dendritic cells and other leukocytes. J. Exp. Med. 154:1981;168-179.
22. Steinman R.M., Gutchinov B., Witmer M.D., Nussenzweig M.C. Dendritic cells are the principal stimulators of the primary mixed leucocyte reaction in mice. J. Exp. Med. 157:1983;613-627.
23. Swiggard W.J., Mirza A., Nussenzweig M.C., Steinman R.M. DEC-205, a 205-kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization, and N-terminal amino acid sequence. Cell. Immunol. 165:1995;302-311.
24. Lefkovits I., Waldmann H. Limiting dilution analysis of the cells of the immune system. Part I: The clonal basis of the immune response. Immunol. Today. 5:1984;265-272.
25. Reiner S.L., Zheng S., Corry D.B., Locksley R.M. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:1993;37-46.
26. Lees C.J., Apostolopoulos V., Acres B.A., Ong C-S., Popovski V., McKenzie I.F.C. The Effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1. Cancer Immunol. Immunother. 48:2000;644-652.
27. Gao X., Rhodes J. An essential role for constitutive Schiff base-forming ligands in antigen presentation to murine T cell clones. J. Immunol. 144:1990;2883-2890.
28. Tan M.C., Mommaas A.M., Drijfhout R., Jordens J., Onderwater J.J., Verwierd D., Mulder A.A., van der Heiden, A.N., Scheidegger D., Oomen L.C.J.M., Ottenhoff T.H.M., Tulp A., Neefjes J.J., Koning F. Mannose receptor-mediated uptake of antigens strongly enhances HLA Class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27:1997;2426-2432.
29. Engering A.J., Cella M., Fluitsma D., Brockhaus M., Hoefsmit E,C., Lanzavecchia A., Pieters J. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27:1997;2417-2425.
30. Wileman T., Boshans R.L., Stahl P. Uptake and transport of mannosylated ligands by alveolar macrophages. J. Biochem. 260:1985;7387-7393.
31. Prigozy T.I., Sieling P.A., Clemens D., Stewart P.L., Behar S.M., Porcelli M.B., Modlin R.L., Kronenberg M. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 6:1997;187-193.
32. Billiau A., Heremans H., Vermeire K., Matthys P. Immunomodulatory properties of interferon-gamma. An update. Ann. NY Acad. Sci. 29:1998;22-30.
33. Pulendran B., Lingappa J., Kennedy M.K., Smith J., Teepe M., Rudensky A., Maliszewski C.R., Maraskovsky E. Developmental pathways of dendritic cells in vivo: distinct function, phenotype and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159:1997;2222-2231.
34. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:1999;77-92.
35. Martinez-Pomares L., Mahoney J.A., Kaposzta R., Lineham S.A., Stahl P.D., Gordon S. A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum. J. Biol. Chem. 273:1998;23376-23381.
36. Lineham S.A., Martinez-Pomares L., Stahl P.D., Gordon S. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J. Exp. Med. 189:1999;1961-1972.
37. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide or tumor lysate pulsed dendritic cells. Nat. Med. 4:1998;328-334.
38. Apostolopoulos V, Pietersz GA, Gordon S, Martinez-Pomares L, McKenzie IFC. Aldehyde-mannan antigen complexes target the MHC Class I antigen presentation pathway. Eur J Immunol 2000, in press.